The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

David Moss Biography and Net Worth

CFO of INmune Bio

Mr. Moss has been CFO since the formation of the Company in September 2015. Mr. Moss has founded, funded and taken public various companies in a variety of industries since 1995. Mr. Moss was a founding investor in Reliant Service Group LLC, which was acquired in 2015 by a leading private equity firm. Mr. Moss previously served as Managing Director, Corporate Finance for a New York-based securities firm, where he advised companies on corporate strategy, financings and business development. Prior to that, he served as Managing Partner at a Seattle-based venture capital firm. Mr. Moss holds an MBA from Rice University and a BA in Economics from the University of California, San Diego.

What is David J. Moss' net worth?: The estimated net worth of David J. Moss is at least $5.86 million as of September 30th, 2024. Mr. Moss owns 1,285,869 shares of INmune Bio stock worth more than $5,863,563 as of November 21st. This net worth approximation does not reflect any other investments that Mr. Moss may own. Additionally, Mr. Moss receives an annual salary of $394,900.00 as CFO at INmune Bio. Learn More about David J. Moss' net worth.
How old is David J. Moss?: Mr. Moss is currently 54 years old. There are 2 older executives and no younger executives at INmune Bio. The oldest executive at INmune Bio is Dr. Raymond Joseph Tesi M.D., Co-Founder, President, CEO, Chief Medical Officer & Chairman, who is 68 years old. Learn More on David J. Moss' age.
What is David J. Moss' salary?: As the CFO of INmune Bio, Inc., Mr. Moss earns $394,900.00 per year. The highest earning executive at INmune Bio is Dr. Raymond Joseph Tesi M.D., Co-Founder, President, CEO, Chief Medical Officer & Chairman, who commands a salary of $500,500.00 per year. Learn More on David J. Moss' salary.
How do I contact David J. Moss?: The corporate mailing address for Mr. Moss and other INmune Bio executives is 1200 PROSPECT STREET SUITE 525, LA JOLLA CA, 92037. INmune Bio can also be reached via phone at (858) 964-3720 and via email at [email protected]. Learn More on David J. Moss' contact information.
Has David J. Moss been buying or selling shares of INmune Bio?: David J. Moss has not been actively trading shares of INmune Bio over the course of the past ninety days. Most recently, on Monday, September 30th, David J. Moss bought 10,000 shares of INmune Bio stock. The stock was acquired at an average cost of $5.29 per share, with a total value of $52,900.00. Following the completion of the transaction, the chief financial officer now directly owns 1,285,869 shares of the company's stock, valued at $6,802,247.01. Learn More on David J. Moss' trading history.
Who are INmune Bio's active insiders?: INmune Bio's insider roster includes Mark Lowdell (Insider), David Moss (CFO), Timothy Schroeder (Director), and Raymond Tesi (CEO). Learn More on INmune Bio's active insiders.
Are insiders buying or selling shares of INmune Bio?: During the last twelve months, INmune Bio insiders bought shares 4 times. They purchased a total of 38,070 shares worth more than $236,436.60. The most recent insider tranaction occured on September, 30th when CFO David J Moss bought 10,000 shares worth more than $52,900.00. Insiders at INmune Bio own 35.2% of the company. Learn More about insider trades at INmune Bio.
Information on this page was last updated on 9/30/2024.

David J. Moss Insider Trading History at INmune Bio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/30/2024	Buy	10,000	$5.29	$52,900.00	1,285,869
9/12/2024	Buy	7,690	$6.38	$49,062.20	1,275,869
3/17/2023	Buy	2,500	$6.42	$16,050.00	1,250,151
5/26/2022	Buy	7,700	$6.27	$48,279.00	1,244,651
11/3/2021	Sell	1,025	$20.00	$20,500.00
10/27/2021	Sell	2,079	$20.00	$41,580.00
10/25/2021	Sell	13	$20.00	$260.00
10/22/2021	Sell	1,142	$20.00	$22,840.00
7/7/2021	Sell	8,698	$20.01	$174,046.98
8/20/2019	Buy	3,000	$5.65	$16,950.00
5/6/2019	Buy	5,000	$9.00	$45,000.00

David J. Moss Buying and Selling Activity at INmune Bio

INmune Bio Company Overview

INmune Bio, Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which is in Phase 1 for the treatment of patients with high-risk myelodysplastic syndrome; and INB03, a mucinous polyglucan on the surface of some epithelial cancer cells that appears to predict resistant to immunotherapy, including women with MUC4 expressing HER2+ breast cancer and other MUC4 resistant cancers. It also provides XPro1595 for the treatment of Alzheimer's disease and treatment resistant depression. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; and University of Pittsburg. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.

Today's Range

Now: $4.56

$4.45

$4.70

50 Day Range

MA: $5.46

$4.71

$6.43

2 Week Range

Now: $4.56

$4.45

$14.74

Volume

185,387 shs

Average Volume

263,449 shs

Market Capitalization

$101.10 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.85

Financial Prophecy

From Porter & Company | Ad

Including the name of the #1 company to buy.

David Moss Biography and Net Worth

What is David J. Moss' net worth?

How old is David J. Moss?

What is David J. Moss' salary?

How do I contact David J. Moss?

Has David J. Moss been buying or selling shares of INmune Bio?

Who are INmune Bio's active insiders?

Are insiders buying or selling shares of INmune Bio?